A review of immediate drug release dosage forms
Abstract
Tablets are currently the most widely used dosage form due to their ease of self-administration, compactness, and simple production. In many situations, rapid action is necessary rather than conventional therapy. Immediate release dosage forms have become an alternative to traditional oral dose forms in order to address these shortcomings. Immediately after administration, immediate medication release dose forms dissolve more quickly. Super disintegrants such carboxymethylcellulose (Croscarmellose), sodium starch glycolate (Primogel, Explotab), cross-linked polyvinylpyrrolidone (Polyplasdone), and others are employed as the fundamental method in the manufacture of tablets. After being administered to the stomach, these powerful disintegrants instantly dissolve tablets. In this area, parenteral dosage forms and instant release liquid dosage forms have both been introduced for the treatment of patients. It is possible to administer suspensions in liquid dose form using common dispersion agents as hydroxypropyl methylcellulose, AOT (dioctyl sulfosuccinate), etc. Many medications, including neuroleptics, cardiovascular medications, analgesics, antihistamines, and other medications, can be thought of as candidates for this dose form as a result of the advent of immediate release therapy. Pharmaceutical companies frequently create a certain medication entity in a new and improved dosage form as the drug entity's patent life is about to expire. While providing its patient group with a more practical dosage form or dosing schedule, a new dosage form enables a producer to extend market exclusivity.
Downloads
References
2. Reddy KM et al. Formulation and evaluation of immediate release tablets of linezolid. International Journal of Pharmaceutical & Biological Archives 2011; 2(4): 1230-1235.
3. Patel U, Patel K, Shah D, Shah R. A review on immediate release drug delivery system. International journal of pharmaceutical research and bio-science. 2012; 1(5): 37-66.
4. Sandeep N, Gupta MM. Immediate drug release dosage form: a review. Journal of drug delivery & therapeutics. 2013; 3(2): 155 - 161.
5. Patel N, Naruka PS, Chauhan CS, Modi J. Formulation Development and Evaluation of Immediate Release Tablet of Topiramateanti Epileptic Drug. Journal of Pharmaceutical Science and Bioscientific Research. 2013; 3(2): 58 – 65.
6. Singh, A., Srinivasan, A.K., Chakrapani, L.N. and Kalaiselvi, P., 2019. LOX-1, the common therapeutic target in hypercholesterolemia: a new perspective of antiatherosclerotic action of aegeline. Oxidative medicine and cellular longevity, 2019.
7. Patel N, Natarajan R, Rajendran NN, Rangapriya M. Formulation and evaluation of immediate release bilayer tablets of telmisartan and hydtochlorothiazide. International journal of pharmaceutical sciences and nanotechnology. 2011; 4 (3): 1477-1482.
8. Dandare MS et al. Bilayer tablet: A Novel approach for immediate release of telmisartan and hydrochlorthaizide combination. International Journal of Pharmacy & Technology April 2012; 4(1): 3970-3983.
9. Singh, A., Gowtham, S., Chakrapani, L.N., Ashokkumar, S., Kumar, S.K., Prema, V., Bhavani, R.D., Mohan, T. and Sathyamoorthy, Y.K., 2018. Aegeline vs Statin in the treatment of Hypercholesterolemia: A comprehensive study in rat model of liver steatosis. Functional Foods in Health and Disease, 8(1), pp.1-16.
10. Loyd Allen V, Nicholas, Popo vich G and Howard Ansel C. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery System, 8th edition. 233
11. Fast Dissolving Tablet: An Overview, Journal of Chemical and Pharmaceutical Research, 2009, 1(1): 163-177
12. Singh, A., Kumar, A. and Kalaiselvi, P., 2018. Aegeline, targets LOX1, the receptor for oxidized LDL to mitigate hypercholesterolemia: a new perspective in its anti-atherosclerotic action. Free Radical Biology and Medicine, 128, p.S41.
13. Dali Shukla, Subhashis Chakraborty, Sanjay Singh, Brahmeshwar Mishra, Mouth Dissolving Tablets II: An Overview of Evaluation Techniques, www.scipharm.at
14. Susijit Sahoo, B. Mishra, P.IK. Biswal, Omprakash Panda, Satosh Kumar Mahapatra, Goutam Kumar Jana, Fast Dissolving Tablet: As A Potential Drug Delivery System, Drug Invention Today 2010, (2), 130-133
15. Singh, A., 2022. Role of microbial metabolites in cardiovascular and human health. In Microbiome, Immunity, Digestive Health and Nutrition (pp. 137-148). Academic Press.
16. A Gupta, AK Mishra, V Gupta, P Bansal, R Singh, AK Singh, Review Article, Recent Trends of Fast Dissolving Tablet - An Overview of Formulation Technology, International Journal of Pharmaceutical & Biological Archives2010; 1(1): 1 – 10
17. Singh, A., 2022. Hyperlipidemia in cardiovascular health and digestion. In Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health (pp. 141-150). Academic Press.
18. A Review on New Generation Oro dispersible Tablets and Its Future Prospective, Tanmoy Ghosh, Amitava Ghosh and Devi Prasad, International Journal of Pharmacy and Pharmaceutical Sciences, 2011;3(1):1491.
19. Roh, J., Hill, J.A., Singh, A.,Valero-Muñoz, M. and Sam, F., 2022. Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circulation Research, 130(12), pp.1906-1925.
20. Reddy.L.H et al., “Fast dissolving drug delivery systems: A review of the literature, IJPS., July 2002:331-336.
21. Shiv Chandra Singh, A., Yu, A., Chang, B., Li, H., Rosenzweig, A. and Roh, J.D., 2021. Exercise Training Attenuates Activin Type II Receptor Signaling in the Aged Heart. Circulation, 144(Suppl_1), pp.A14259-A14259.
22. Vaishnavi R et al. Formulation and evaluation of immediate release tablets of paroxetine HCl using different super disintegrants. International Journal of Research in Pharmaceutical and Biomedical Sciences Sept 2011; 2(3): 1095- 1099.
23. Prasanth Sai R.V., I. Pujitha, Srinivas Thota and Nagu A. Formulation and Development of Entecavir Tablets; International Journal of Research in Pharmaceutical and Biomedical sciences 2011; 2 (3) :1239-1247.
24. Boini, K.M., singh, A. and Koka, S.S., 2021. Gut Microbial Metabolite Trimethylamine N-oxide Enhances Endoplasmic Reticular Stress and Promotes Endothelial Dysfunction. Circulation, 144(Suppl_1), pp.A14071-A14071.
25. Dhakane K et al. Fast dissolving tablet: A Future prospective. Journal of Pharmacy Research 2011; 4(11): 4176-4180.
26. Ravichandran V et al. Fast dissolving tablets: A Review. Journal of Pharmacy Research 2011; 4(8): 2590-2592.
27. Theobald N, Winder B. Packaging Closures and Sealing Systems. Blackwell Publishing Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK; First published 2006

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.